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The host inflammatory response to infection and tissue injury is characterized
byincreasedbloodflow, changes in vascularpermeability, and margination and emigra-
tion ofleukocytes. A numberofwell-characterized macrophage-derived mediators,
including cachectin/TNF and IL-1, have been implicated in these processes (1, 2).
Other, newly-isolated monokines are suspected to play an important role as well.
Recently, we reported the purification ofone suchmonokine, aheparin-binding protein
secretedbymacrophages in response tostimulation byLPS (3). Thisnovel monokine,
referred to as macrophage inflammatory protein 1 (MIP-1), 1 causes a local inflam-
matory response when injected into the footpads of C3H/Hej mice, and induces
superoxide production in human neutrophils in vitro (3). In vitro, it is also mildly
chemokinetic forhumanneutrophils. Sinceone hallmarkofinflammation isthemobili-
zation and activation ofneutrophils, we conjecture that MIP-1 may bean important
endogenous mediator of acute or chronic inflammation.
On SDS-PAGE, purified native murine MIP-1 migrates as a doublet composed
of peptides with nearly identical apparent mol wt of -8,000 (3). NH2-terminal
amino acid sequence analysis ofnative MIP-1 reveals one dominant sequence with
minor amino acids at several positions. A synthetic oligonucleotide probe pool cor-
responding to the dominant NH2-terminal amino acid sequence was used to iso-
late acDNA clonecontaining the coding sequence formurine MIP-1 (4). This cDNA
clonehas nowbeen sequenced (4) andexpressedin yeast (unpublished work). From
this initial work, however, it had not been possible to distinguish whether the two
peptide bands ofpurified "doublet" represented two allelic forms ofthe same gene
product, two alternative splicings ofa unique genetic locus, or differingproteolytic
digests of a single mature protein.
Toclarify thenature ofthe MIP-1 doublet, wechromatographically separatedand
partially sequenced the two component peptides. This resolution allowed us to at-
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tribute our previous MIP-1 cDNA clone to one peptide (MIP-la), and to clone a
second cDNA corresponding to the second peptide (MIP-1ß) ofthe originally purified
MIP-1 doublet. The MIP-1a and MIP-lß cDNA clones are clearly distinct but highly
homologous, share several common features in noncoding flanking regions, code
for homologous proteins whose predicted hydrophilicity profiles are strikingly similar,
and help to define a growing family of closely related proteins produced by various
"activated" cell types.
Materials and Methods
Cell Culture.
￿
The mouse macrophage cell line RAW 264.7 was obtained from American
Type Culture Collection (Rockville, MD). Cells were maintainedas described previously (3).
Conditioned medium from LPS-stimulated cells was generated as follows: RAW 264.7 cells
were grown in 150-mm tissue culture dishes (Falcon Labware, Oxnard, CA) in RPMI 1640
culture medium supplemented with 10% FCS until they reached confluency. Confluent
monolayers were washed five times in HBSS and covered with serum-free RPMI 1640 con-
taining 1.0 ug/ml LPS (LPS W, E. coli 0127 :B8; Difco Laboratories, Inc., Detroit, MI). After
incubation at 37°C for 16 h, conditioned medium was harvested, filtered through a 0.22-gm
filter, and stored frozen at -20°C until use.
Purification ofMIP-1ß.
￿
MIP-1 was purified as described previously (3) . In brief, condi-
tioned medium from LPS-stimulated RAW 264.7 cells was concentrated 20-fold and diafiltrated
against 0.02 M Tris/HCl buffer, pH 8.0, usinga hollow fiberconcentration system equipped
with a 10,000-molwt cutoff (DC 2; Amicon Corp., Danvers, MA). Octyl glucoside was added
to a final concentration of 1% (wt/vol), and the MIP-1-containing concentrate was fraction-
ated over a Mono Q 10:10 anion exchange column (Pharmacia Fine Chemicals, Piscataway,
NJ) in 0.02 M Tris/HCl buffer, pH 8.0. A linear gradient from 0 to 1.0 M NaCl was used
to elute adsorbed proteins. MIP-1 was monitored throughoutby its pattern of migration on
SDS-PAGE. MIP-1-containing fractions were pooled, concentrated, and subjected to high
performance gel filtration chromatography over a Superose 12 column (Pharmacia Fine Chem-
icals) equilibrated in 0.1 M ammonium acetate buffer, pH 7 .4. As described previously, MIP-1
eluted in the void volume (3). Fractions containing MIP-1 were pooled, concentrated using
a PM-10 membrane in a stirred cell (Amicon Corp.), and diafiltrated against 0.01 M sodium
phosphate buffer, pH 6.4. The two components of MIP-1 were then resolved by SDS-
hydroxylapatite chromatography according to the procedure of Moss and Rosenblum (5).
In brief, a 500-wg aliquot of MIP-1 was equilibrated in 0.01 M sodium phosphate buffer,
pH 6.4, containing 1% SDS and 1% mercaptoethanol and placed in a boiling water bath
for 2 min. The sample was immediately diluted 10-fold with 0.01 M sodium phosphate buffer
(pH 6.4) containing 0.1 % SDS and 1.0 mM dithiothreitol (DTT) (buffer A), applied directly
to a hydroxylapatite column (Bio Gel HPHT; Bio-Rad Laboratories, Richmond, CA) pre-
equilibrated in buffer A. A 25-ml linear gradient from 0.01 to 0.35 M sodium phosphate
buffer (pH 6.4) containing 0.1% SDS and 1 .0 mM DTT was used for elution.
Protean Determination.
￿
Protein concentration was measured by Bradford assay (6) with BSA
as standard (Bio-Rad Laboratories).
Protein Sequencing.
￿
NH2-terminal amino acid sequence analysis of MIP-1a and MIP-lß
were performed on a gas phase sequenator(Applied Biosystems, Inc., Foster City, CA). The
Dayhoff protein sequence bank was searched for homologous amino acid sequences using
the computer program FASTR
Hydrophilicity Plots.
￿
The hydrophilicity plots of MIP-la and MIP-lß were calculated by
a modification of the algorithm of Hopp and Woods (7).
Construction ofcDNA Library.
￿
A cDNA library from LPS-stimulated RAW 264.7 cells was
obtained as described previously (4). In brief, confluent monolayers of RAW 264.7 cells were
washed five times in HBSS and covered with serum-free RPMI 1640 culture medium con-
taining 1.0 gg/ml LPS. After incubation at 37°C for 2 h, total RNA was extracted into 6
M guanidinium thiocyanate (8). Poly(A)' RNA was then isolated by two cycles of
oligodT-cellulose chromatography according to the procedure ofManiatis et al. (9). dscDNASHERRY ET AL. 2253
was prepared from the poly(A)' RNA according to the procedure of Gubler and Hoffman
(10). Internal Eco RI sites were methylated, Eco RI linkers added, and the cDNA was in-
serted into the Eco RI sites of bacteriophage X gt10 (11).
Construction ofthe ProbePools.
￿
An oligonucleotide probe pool corresponding to amino acids
2-8 of a partial NH2-terminal sequence of MIP-1 ß were synthesized as described by Warner
et al. (12). This particular sequence was chosen because it was the region of least apparent
homology between the dominant (MIP-la) and minor (MIP-10) sequences.
Screening of the Library.
￿
Duplicate nitrocellulose filter lifts of the plated library (4 x 105
plaques) were hybridized overnight at 42'C in 4 x SSC, 2X Denhardt's solution, 40 mM
sodium phosphate buffer, pH 7 .0, 0.3 mg/ml sonicated salmon sperm DNA, 0.1% SDS, and
2 .5-5 x 104 cpm/ml per degeneracy of the 32P-ATP Tend-labeled synthetic oligonucleotide
probe pool. After hybridization, the filters were washed; the final washes were done under
conditions of moderate stringency: 2X SSC, 0.1% SDS at 50°C . Plaques that were positive
on duplicate filters were subjected to a second round of low density plating and screening.
In this way two independent positive phage clones were isolated from which DNA was pre-
pared for further analysis.
DNA Sequence Analysis.
￿
The cDNA inserts to be analyzed were subdoned into M13 phage
vectors and DNA sequencing was performed by the dideoxy chain termination method of
Sanger et al. (13) .
Results and Discussion
As described previously, native murine MIP-1 is isolated as a doublet with a subunit
mol wt of -8,000 (3). Although the two components are separated to some extent
by SDS-PAGE, their electrophoretic mobilities are so similar that preparative SDS-
PAGE appeared an impractical means of purification. We subjected native MIP-1
to SDS-hydroxylapatite chromatography, a technique that has been used success-
fully to separate protein subunits of similar electrophoretic mobility (5). As can be
seen in Fig. 1, two distinct protein peaks are observed after fractionation of native
MIP-1 on a hydroxylapatite column in the presence of SDS. The first peak elutes
at 0.24 M sodium phosphate and the second at 0.27 M sodium phosphate. SDS-
PAGE analysis of the column fractions revealed that the first peak corresponded to
the lower mol wt band ofMIP-1, while the second peak corresponded to the higher
mol wt band. Using this technique, each component was obtained in pure form
(>950 /c as judged by SDS-PAGE) for NH2-terminal amino acid sequence analysis.
The NH2-terminal amino acid sequence of the lower mol wt component of MIP-1
(now referred to as MIP-la) is shown in Fig. 2 A. The N142-terminal amino acid
sequence reported here is identical to the dominant sequence obtained when native
MIP-1 (doublet) was sequenced previously (3). The NH2-terminal sequence anal-
î 0075
E
°~ 0050
N
d
0
e
0025
á
a
SDS-Hydroxylopatite Chromatography
1 z
5 10 15 20 25 30 35 40 45
Fraction Number
60 m
á
FIGURE 1.
￿
Fractionation ofMIP-1 into compo-
nent peptides by SDS-hydroxylapatite chroma-
tography. MIP-1 (500 ug) was applied to SDS-
hydroxylapatite and fractionated as described in
Materials andMethods. 0.5-ml fractions were col-
lected, analyzed by SDS-PAGE, and pooled as
indicated by the brackets (1, MIP-la; 2,
MIP-1 ß).2254 RESOLUTION OF MACROPHAGE INFLAMMATORY PROTEIN 1
a
ala-pro-tyr-gly-ala-asp-thr-pro-thr-sla- X - X -phe-ser-tyr-ser-arg-lys-ile-
pro-arg-gln-phe-ile-val-asp-tyr-phe-glu-thr-ser-
B
ala- pro-av;t-olv-ser-asp-pro-oro -thr-ser- X - X -phe- X -tyr-
C
(set) (pro)
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FIGURE 2 . (A) NH2-terminal
amino acid sequence ofpurified
MIP-la; (B) NH2-terminal
amino acid sequence of MIP-
lp. The residues underscored
(2-8) were those used to con-
struct an oligonucleotideprobe
pool for MIP-10; (C) Original
NH2-terminal aminoacid con-
sensus sequence reported for
purified native MIP-1 (doublet).
Residues corresponding to
minor amino acidsat variance
with thedominant sequence are
given in parenthesis. Thesese-
quence data have been sub-
mitted to theEMBL/GenBank
Data Libraries undertheacces-
sion number Y00801.
ysis ofthe higher mol wt component of MIP-1 (now referred to as MIP-1R) is shown
in Fig. 2 B. The minor amino acids observed at positions 3 and 7 in the original
NH2-terminal sequence correspond to differences in amino acid residues between
MIP-la and MIP-1(i. In Fig. 2 C, the original NH2-terminal amino acid consensus
sequence fornative MIP-1 is given for comparison (3). It is clear from the nucleotide
sequence reported by Davatelis et al. (4) that the MIP-1 cDNA clone corresponds
to MIP-la, ruling out proteolytic digestion as a source of the two bands of MIP-1.
A cDNA clone containing the coding sequence forMIP-1(i was isolated and charac-
terized. To accomplish this, a cDNA library from LPS-stimulated RAW 264.7 cells
was prepared according to the procedure described in Materials and Methods. The
oligonucleotide probe pool used to screen the cDNA library was generated against
the sequence underscored in Fig. 2 B. Three of these seven MIP-1p amino acids
differ from the corresponding sequence of MIP-1a. The probe pool used to screen
the library was 5'-CXATGGGXAECGACCCXCC-3: The third position choices
were made based on thecodon usage reported for cloned murine genes and thecodon
usage of MIP-la (13).
Utilizing the labeled probe pool, the library was screened under conditions of
moderate stringency. Two independent clones were isolated out of 4 x 105 recom-
binant phage plaques screened. This was a considerably lower frequency than ex-
pected. Upon DNA sequencing of the isolated clones, it was found that the choice
of C forthe thirdposition ofthe Ser5 codon was incorrect; it was actually a T, thereby
resulting in no perfect match of any probe pool sequence to the actual MIP-1(3 se-
quence. Thus, MIP-1R sequence representation in the library is likely to be underes-
timated based on hybridization with this probe pool. Subsequent screening of the
library with unique oligonucleotide probes specific for comparable regions of MIP-
1a and MIP-1(i indicate that MIP-1(i-specific sequences are fivefold less abundant
than MIP-la sequences.
After plaque purification, DNA inserts (-700 bp) from the two positive recom-
binant phage were shown to crosshybridize to the full MIP-la cDNA probe. Insert
cDNA was isolated from each recombinant phage population, cloned into m13, and
the complete nucleotide sequence was determined. The two nucleotide sequencesdiffered only in the length of 5' untranslated sequence present; the longer nucleotide
sequence is presented in Fig. 3.
The MIP-1a cDNA is 650 by long; whichby primer extension analysis is no more
than 11-12 nucleotides short ofacomplete cDNA sequence. The nucleotide sequence
of MIP-10 contains a single open reading framebeginning with the first ATG codon
encountered at the 5' end of the sequence (nucleotides +62 to +64) after an in-
frame stop codon. The methionine specifiedby this codon defines the start of a signal
sequence (residues -23 and -1) with characteristic features including a helix and
a centrally located hydrophobic region (14). The sequence surrounding this ATG
codon conforms to the consensus sequence shared by many mRNAs of higher eu-
karyotes (15).
The TGA termination triplet is located 91 codons downstream of the initiating
codon. The 3' untranslated region of MIP-1(i is composed of 315 nucleotides and
contains the hexanucleotide AATAAA (nucleotides +283 to +288), which precedes
the site of polyadenylation in many eukaryotic mRNAs (16).
There is a single sequence at nucleotides +174 to +181 that precisely matches
the cytokine 3' untranslated consensus sequence (TTATTTAT) defined by Caput
et al. (17) that is characteristic of many immunomodulatory proteins. In addition,
there are two additional sequences present that have a single mismatch to this con-
sensus sequence (nucleotides +165 to +172 and nucleotides +185 to +192).
The mature peptide sequence, starting at position 1, is 69 amino acids in length.
Marine KIP1Q
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FIGURE 3.
￿
The complete nu-
deotide sequence ofthe cDNA
clone for MIP-1p is shown. The
predicted translated mol wt is
10,169. The mature protein se-
quence, starting at position one,
is 69 amino acids in length and
has a predicted molwt of7,832.
These sequence data have been
submitted to the EMBL/Gen-
Bank Data Libraries under the
accession number Y00801.2256
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The mature protein, as determined from its cDNA clone, has a mol wt of 7,832,
which agrees with the mol wt predicted by SDS-PAGE. The amino acid sequence
predicted from the cloned cDNA sequence is consistent with the first 13 amino acids
obtained from NH2-terminal amino acid sequencing of purified native MIP-lß .
MIP-1 ß has a single N-linked glycosylation site present in the mature protein at
amino acids 53-55 (Asn-Pro-Ser). Whether native MIP-1 is actually glycosylated
at this position has not yet been determined, but it is well recognized that proline
at position X in the Asn-X-Ser, Thr signal for N-linked glycosylation results in im-
paired or no glycosylation at that site (18). Hydrophilicity plots for MIP-la and MIP-
1 R, which indicate the predicted polarity profiles of the two proteins, are shown in
Fig. 4 . It is clear from Fig. 4 that the local polarity distribution within MIP-la and
MIP-10 are strikingly similar.
The entire nucleotide sequence of murine MIP-lß cDNA was compared with se-
quences in the GenBank nucleotide database (rodent, primate, other mammals, and
other vertebrate libraries) as well as to the MIP-la cDNA sequence (4). The MIP-
10 and MIP-la cDNAs are 56.7% identical; the only significant homology found
in GenBank was to cDNA clone pLD78 isolated from a human T cell lymphocyte
cDNA library on the basis of its mRNA induction by either a tumor promoter or
PHA (19). Murine MIP-1ß cDNA showed 57 .1% identity in a 592-nucleotide overlap
to human LD78 cDNA. Murine MIP-la cDNA showed even higher homology, 69%
identity in a 746 nucleotide overlap.
When the predicted amino acid sequence of MIP-10 was tested for homology to
sequences in the Dayhoffdata base using the FASTP computer homology algorithm,
no strikingly high homology was found. However, comparison of the predicted pro-
tein sequences of murine MIP-1ß, murine MIP-la, human LD78, as well as the
recently reported predicted sequences for the PDGF, IL-1, and dsRNA-inducible
murine cytokine JE (20), and a murine T cell activation protein, TCA3 (21), indi-
cates that these proteins are clearly homologous (Fig. 5). The deduced amino acid
sequence of MIP-1ß shows 59.8% identity to that of MIP-la, and 58.7%, 38.9%,
and 31.9% identity to the predicted amino acid sequences of LD78, JE, and TCA3,
respectively. Common to all these sequences is the presence of four conserved cys-
teines in each of the mature protein sequences. Interestingly, the predicted amino
acid sequence of murine MIP-la is more homologous to that of human LD78 (75 .3%
FIGURE 4.
￿
Hydrophilicity plots of MIP-la
(-----)andMIP-10 (
￿
) indicating the
calculated polarity profiles ofthetwopeptides.
They-axisrepresents hydrophilicity values de-
rived by a modification of the Hopp and
Woodsalgorithm (7). The x-axis shows posi-
tion along the amino acid sequence.SHERRY ET AL .
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FIGURE 5 .
￿
Homology of MIP-1ß and related proteins . Sequences (cDNA) were obtained from
the literature and the predicted protein sequences were aligned using the FASTP program al-
gorithm . Amino acids that are identicalbetween at least two sequences are enclosed in shaded
boxes . (_) The NH2-terminal of the putative mature protein as determined by NH2-terminal
sequence analysis of purified secreted protein . (" ) The NH2-terminal amino acid predicted to
be the start of the mature protein . Small case prefixes refer to species : mu, murine ; hu, human .
References for sequences are as follows : MIP-1ß (this work) ; MIP-la (4) ; LD78 (19); JE (21) ;
and TCA3 (20).
identity) than it is to the predicted amino acid sequence of MIP-lß (59.8% iden-
tity) . Thus, theseproteins share similarities in sequence that appear to define afamily
of peptides that may be involved in inflammatory and/or immune responses .
The quaternary structure of native MIP-1 has not yet been determined . The two
component peptides, MIP-1a and MIP-1 ß, appear to be produced in equal amounts
by macrophages in response to LPS. Further work should elucidate any relationship
that exists between these two proteins . In particular it is important to determine
if a combination ofboth components is required for some or all of the bioactivities
exhibited by purified native MIP-1. This work is currently in progress . The avail-
ability of recombinant MIP-1a and MIP-1ß will help to reveal other activities as-
sociated with this monokine as well .
Summary
Anumber ofmacrophage-derived mediatorshave been implicated in the vascular
changes of inflammation . We recently reported the isolation of a novel monokine,
macrophage inflammatory protein l (MIP-1), which causes local inflammatory re-
sponses in vivo, and induces superoxide production by neutrophils in vitro. Purified2258
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native MIP-1 comprises two peptides with very similar physical characteristics. We
report here the resolution of MIP-1 into component peptides by SDS-hydroxylapatite
chromatography, and compare the NH2-terminal sequences of the two peptides,
now referred to as MIP-la and MIP-1a. A synthetic oligonucleotide probe pool cor-
responding to the NH2-terminal amino acid sequence of MIP-1(3 was used to iso-
late a cDNA clone containing its coding sequence. The sequence codes for a 109
amino acid-long polypeptide, of which 69 amino acids correspond to the mature
product. Comparison of this MIP-1(i cDNA with our previously cloned MIP-1a se-
quence reveals that the MIP-1 peptides, members of a growing family of potential
inflammatory mediators, are distinct but highly homologous (58.9% sequence identity)
products of different genes.
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